Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement

Affiliations

• ¹ Department of Children and Adolescents Oncology, Gustave Roussy Cancer Center, Paris-Saclay University, Villejuif. [email protected].
• ² Department of Children and Adolescents Oncology, Gustave Roussy Cancer Center, Paris-Saclay University, Villejuif.
• ³ Department of Pediatric Oncology and Hematology, Bordeaux University hospital, Bordeaux.
• ⁴ Department of Pediatric Oncology and Hematology, Armand Trousseau Hospital- APHP, Paris.
• ⁵ Department of Pediatric Hematology, Robert Debré Hospital- APHP, Paris.
• ⁶ Department of Pediatric Oncology and Hematology, Besançon University Hospital, Besançon.
• ⁷ Department of Pediatric Oncology and Hematology, Saint-Denis de la Réunion University Hospital.
• ⁸ Department of Pediatric Hematology, Lille University Hospital, Lille.